| Top 50 Most Viewed Posts Last Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. dfwl28: Cytodyn Shareholders Community Michael Fumelle · (1193)  (9) |
| 2. twinter11: Exceptionally broad HIV-1 neutralization via (1096) (9) |
| 3. My69z: Key to many LL approvals: Lung, Breast, Prostate, (927) (2) |
| 4. MJS719: Thank you brentie for the reminder of how (823) (10) |
| 5. Cycl2R: I don’t believe it has been noted here that the (820) (12) |
| 6. Ganesha: Re: Current EIND policy at CYDY I wanted to let (724) (40) |
| 7. MGK_2: Patient A, is a 78-year-old female with a (721) (15) |
| 8. Katangolo: Excellent observation! Didn’t work the first (699) (6) |
| 9. Enjay: I am posting this because of the ongoing (676) (9) |
| 10. Rosner: Short Interest Report As of Sat, Aug 3, '13 (638) |
| 11. brentie: CytoDyn's Strategic Positioning in Biopharma: A (630) (22) |
| 12. Crujones1985: I kind of think Dr Jay got a lot accomplished (618) (25) |
| 13. ohm20: The new research, though, highlights much smaller (601) (17) |
| 14. hoops: Very interesting theory. Buying time after (593) (3) |
| 15. Evil Rabbit: We should see a PR about this in the next week or (568) (16) |
| 16. biloxiblues: This is a good read for the morning (561) (6) |
| 17. Emmitt: My baseball hypothesis: We’re in the playoffs. (550) (12) |
| 18. mountaineer: Quick Summary of 10Q (no surprises that I can (544) (15) |
| 19. CaptnAmerca: CFO Robert E. Hoffman to deliver company (543) (16) |
| 20. HouseofCards: Biloxi, I believe you said you were a stockbroker (542) (10) |
| 21. jrt03: What I believe Dr. Dalton is trying to say from (537) (11) |
| 22. dfwl28: More on Hot and Cold Tumors: Excerpt: “Our (535) (6) |
| 23. Niele: Thanks for the link to the article, Brentie. (524) (5) |
| 24. twinter11: If the incessant complaining on a shareholder (521) (11) |
| 25. ohm20: Interesting interview with Dr. Patrick (520) (20) |
| 26. My69z: Sept Letter & PoC Protocol: Based on the positive (518) (9) |
| 27. Evil Rabbit: I have a very close family member suffering with (517) (17) |
| 28. Buddyboy20: "My construcive suggestions: 1. Thank Stephen (516) (21) |
| 29. SamaGong: Ken, Are you too concerned about your press (515) (20) |
| 30. mountaineer: Something is horribly off today! I bought "the (513) (9) |
| 31. HHIGambler: "There appears to be gobs of safety data to (513) (7) |
| 32. Figgs: I feel the silence over the Summer and the (512) (4) |
| 33. ohm20: With only 19,000 potential patients worldwide (509) (20) |
| 34. dfwl28: Nobel Prize for work in immunology/T cells (506) (1) |
| 35. Mr3Putt: Major shareholders include management. If we’re (502) (10) |
| 36. Evil Rabbit: … every time I say so… I assume that mod is (497) (7) |
| 37. biloxiblues: From the Cytodyn Facebook this morning Grok's (492) (8) |
| 38. ohm20: This is exactly why they’re doing it. It's (488) (25) |
| 39. ohm20: If you add an ICI at this point to the phase 2 (488) (37) |
| 40. Respert24: Nothing would please me more than being asked to (479) (19) |
| 41. smokeandmist: I’m a retired physician with no experience in (477) (15) |
| 42. Crujones1985: I agree Seems like they would be a lot better (472) (7) |
| 43. mightycydy: The current Leronlimab indication pipeline can be (471) (8) |
| 44. Evil Rabbit: There needs to be an explanation for that from (469) (9) |
| 45. Emmitt: ....And he did all that in 23 months in an (467) (11) |
| 46. Evil Rabbit: It’s not about hedge funds, it's about new (465) (6) |
| 47. ohm20: Is esophageal cancer a likely candidate for the (465) (21) |
| 48. biloxiblues: I totally agree and was sharing the post. I also (465) (3) |
| 49. MidnightRider: Mr3 I. Agree 100 % and every time I say so I get (465) (9) |
| 50. ohm20: As mentioned, the positive aspects are posted (455) (9) |
